CervoMed (CRVO) Stock Price
CervoMed Price
Over the last 18 years CervoMed grew revenue by 15.3% annually, reaching 4.01 M USD. For CervoMed, the net margin of -673.1% is up versus -1,834.0% a few years ago. The consensus 12-month price target for CervoMed is 12.24 USD, about 284.9% above where the stock trades today. Of 14 analysts, 8 rate the stock a buy — an overall Buy consensus.
CervoMed stock price
CervoMed business model & stock analysis
Frequently asked questions about CervoMed
12 analysts currently rate the CervoMed stock: 11 recommend buying, 1 holding and 0 selling. For 2026, analysts expect CervoMed to generate revenue of 133,330.00 USD and earnings per share of -2.15 USD.
Converted at the current exchange rate, the CervoMed share trades at 2.84 EUR (3.18 USD).
The CervoMed share (CRVO) is listed on 2 stock exchanges, including: NASDAQ (DFFN), Frankfurt (DP8.F).
The expected revenue of CervoMed is 133,330.00 USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of CervoMed is -19.91 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of CervoMed is currently -1.48. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the CervoMed stock.
The price-to-sales ratio (P/S) of CervoMed is currently 220.68. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the CervoMed stock.
The Eulerpool Quality Score for CervoMed is 3/10.
The ISIN of CervoMed is US15713L1098. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of CervoMed is A3ES01. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of CervoMed is CRVO. The ticker symbol is used to trade CervoMed shares on the stock exchange.
CervoMed stock
CervoMed Peer Group
CervoMed Ticker
CervoMed FIGI
All fundamentals and in-depth analysis of CervoMed
Our stock analysis for CervoMed stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CervoMed. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.